Hybrid Friday Satellite Symposium on Multiple Myeloma,
preceding the 64th ASH Annual Meeting and Exposition
Friday, December 9, 2022
Registration and Lunch
12:00 PM – 12:30 PM CST
Clinical OlympicsSM Symposium
12:30 PM – 2:00 PM CST
New Orleans Ernest N. Morial Convention Center
Great Hall B/C
900 Convention Center Blvd
New Orleans, LA 70130
Also Available to Virtual Attendees via Online Simulcast
FACULTY
Sundar Jagannath, MD, FASCO
Chair, Multiple Myeloma
Professor, Medicine
Icahn School of Medicine at Mount Sinai
Director, Multiple Myeloma Center of Excellence
Tisch Cancer Center Institute
Editor-in-Chief, Clinical Lymphoma, Myeloma & Leukemia
Mount Sinai Hospital
New York, New York (USA)
James Hoffman, MD
Associate Professor, Clinical Medicine
Division of Myeloma (Hematology)
Sylvester Comprehensive Cancer Center (SCCC)
University of Miami
Miami, Florida (USA)
María-Victoria Mateos, MD, PhD
Associate Professor, Hematology
Director, Myeloma Program
University Hospital of Salamanca
Salamanca, Spain (Europe)
Do not miss the first ever Multiple Myeloma Clinical OlympicsSM symposium preceding the ASH 2022! All prospective “Olympians” will join 1 of 3 country teams to compete in a series of clinical events by answering challenge questions (via provided iPads) related to the use of BCMA-targeted therapies in relapsed/refractory multiple myeloma. Individual learners earn points for their team by responding correctly to challenges in each event, after which the big screens will display the Gold, Silver, and Bronze medal winners. In the closing ceremonies of the Clinical OlympicsSM, the all-around winners from all 3 events will be announced, as well as the leaderboard for the top 15 individual performers. Join us for the expert-driven scientific exchange, but also for some friendly competition and fun!
PROGRAM AGENDA
Sundar Jagannath, MD, FASCO
BCMA-Targeted Therapies in R/R MM: The Present
María-Victoria Mateos, MD, PhD
BCMA-Targeted Therapies in R/R MM: A New Era
Sundar Jagannath, MD, FASCO
BCMA-Targeted Therapies in R/R MM: Safety First
James Hoffman, MD
Sundar Jagannath, MD, FASCO
WHO SHOULD ATTEND?
Medical oncologists, hematologists, hematologist-oncologists, pathologists, and oncology nurses
LEARNING OBJECTIVES FOR ATTENDEES
Upon completion of this symposium, participants should be better able to:
- Select an appropriate B cell maturation antigen (BCMA) targeted therapy among approved options for patients with relapsed/refractory (R/R) multiple myeloma (MM)
- Integrate novel BCMA-targeted therapies into the treatment paradigm of R/R MM, with an emphasis on bispecific antibodies
- Manage adverse events (AEs) associated with BCMA-directed therapies in patients with R/R MM
ACCREDITATION
In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Physician Continuing Medical Education
RMEI Medical Education, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.
PROVIDER STATEMENT
This activity is provided by RMEI Medical Education, LLC.
SUPPORTER STATEMENT
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Disclosure of Financial Relationships
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.
Americans WIth Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact RMEI prior to the live event at (866) 770-RMEI.
FEE INFORMATION
There is no fee for this educational activity.
FOLLOW RMEI
Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.